The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy

Ítems similars

• Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
  per: Murray, Nigel P, et al.
  Publicat: (2018)
• The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
  per: Murray, Nigel P, et al.
  Publicat: (2020)
• Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
  per: Murray, Nigel P, et al.
  Publicat: (2019)
• Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
  per: Murray, Nigel P, et al.
  Publicat: (2018)
• The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
  per: Murray, Nigel P, et al.
  Publicat: (2017)